HUWE1 targets mitochondria via RMC1 to promote neurodevelopment
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2619864123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Jiamin Yi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Paediatrics, West China Second University Hospital, State K…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Mitochondria, Zebrafish Proteins, Tumor Suppressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The HECT-type E3 ubiquitin ligase HUWE1 is a critical regulator of protein homeostasis, genome stability, and neurodevelopment. Variants in HUWE1 are linked to X-linked intellectual disability (XLID), yet a significant number of HUWE1 variants are noncatalytic, leaving their disease mechanisms unresolved. Here, we identify an AMBRA1–RMC1–HUWE1 signaling axis that directs HUWE1-mediated ubiquitination to mitochondria to regulate neural development. In zebrafish, noncatalytic HUWE1 variants found in XLID patients (M375I, G660R, and H669Q) recapitulate key neurodevelopmental deficits, including impaired brain growth and motor neuron defects. Global ubiquitin profiling reveals that these variants selectively disrupt the ubiquitination of mitochondrial proteins without affecting nuclear substrates. Mechanistically, AMBRA1 acts as a mitochondrial scaffold that recruits RMC1, enabling HUWE1 localization to mitochondria through direct interaction with RMC1. Disruption of this recruitment by disease-associated HUWE1 variants prevents mitochondrial targeting and impairs mitochondrial substrate ubiquitination. Notably, Urolithin A treatment ameliorates neurodevelopmental phenotypes in HUWE1-deficient zebrafish. Together, our findings define an AMBRA1-organized mitochondrial recruitment pathway in which RMC1 links HUWE1 to mitochondria, explain noncatalytic HUWE1-associated XLID, and suggest mitochondrial quality-control enhancement as a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Paediatrics, West China Second University Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.
- Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Qin Yang, Yingfeng Tu, Da Jia
Zitieren
APA
Yi, J., Yang, Q., Zhou, C., Zhu, Y., Tu, Y., Zhao, L., Tang, M., Qin, J., Long, T., Li, T., Li, P., Gong, Z., Wang, Q., Yong, X., & Jia, D. (2026). HUWE1 targets mitochondria via RMC1 to promote neurodevelopment. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2619864123
Vancouver
Yi J, Yang Q, Zhou C, Zhu Y, Tu Y, Zhao L, et al. HUWE1 targets mitochondria via RMC1 to promote neurodevelopment. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2619864123
BibTeX
@article{Yi2026,
author = {Yi, Jiamin and Yang, Qin and Zhou, Chunzhuang and Zhu, Yunfei and Tu, Yingfeng and Zhao, Lin and Tang, Min and Qin, Junhong and Long, Tao and Li, Tianxing and Li, Ping and Gong, Zikang and Wang, Qilin and Yong, Xin and Jia, Da},
title = {HUWE1 targets mitochondria via RMC1 to promote neurodevelopment},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2619864123}
}
EUVIMED